Investments Ab Kdev serves as Executive at Aprea Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Investments Ab Kdev has executed 2 insider transactions totaling $6.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 13, 2020 involved selling 210,548 shares valued at $6.6M.
Investments Ab Kdev currently holds 2,234,289 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Investments Ab Kdev has been a net seller of APRE stock. They have purchased $0 and sold $6.6M worth of shares.
Investments Ab Kdev's most recent insider trade was on Apr 13, 2020, when they sold 210,548 shares at $31.25 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |